new_0222_0333|CRBU|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0333|CRBU|Long Name|1|1|Caribou Biosciences Inc Total Current Assets (Quarterly) (USD)|Caribou Biosciences Inc Cash and Short Term Investments (Quarterly) (USD)|Caribou Biosciences Inc Inventories (Quarterly) (USD)|Caribou Biosciences Inc Net PP&E (Quarterly) (USD)|Caribou Biosciences Inc Goodwill and Intangibles (Quarterly) (USD)|Caribou Biosciences Inc Total Liabilities (Quarterly) (USD)|Caribou Biosciences Inc Total Current Liabilities (Quarterly) (USD)|Caribou Biosciences Inc Total Long Term Liabilities (Quarterly) (USD)|Caribou Biosciences Inc Total Deposits (Quarterly) (USD)|Caribou Biosciences Inc Book Value (Quarterly) (USD)|Caribou Biosciences Inc Retained Earnings (Quarterly) (USD)|Caribou Biosciences Inc Treasury Stock (Quarterly) (USD)|Caribou Biosciences Inc EV to Revenues|Caribou Biosciences Inc EV to Earnings|Caribou Biosciences Inc EV to Free Cash Flow|Caribou Biosciences Inc EV to Assets (Quarterly)|Caribou Biosciences Inc PS Ratio|Caribou Biosciences Inc PE Ratio|Caribou Biosciences Inc Price to Book Value|Caribou Biosciences Inc PEG Ratio|Caribou Biosciences Inc Debt to Equity Ratio|Caribou Biosciences Inc Dividend Yield|Caribou Biosciences Inc Shareholder Yield (TTM)|Caribou Biosciences Inc Percent of Shares Outstanding Short|Caribou Biosciences Inc Total Receivables (Quarterly) (USD)|Caribou Biosciences Inc Total Payables (Quarterly) (USD)|Caribou Biosciences Inc Total Capital Stock (Quarterly) (USD)|Caribou Biosciences Inc Return on Invested Capital|Caribou Biosciences Inc Quality Ratio Score|Caribou Biosciences Inc Momentum Score|Caribou Biosciences Inc Beta (1Y)|Caribou Biosciences Inc Sustainable Growth Rate (TTM)|Caribou Biosciences Inc Institutional Investor Ownership Percentage|Caribou Biosciences Inc Average Diluted Shares Outstanding (Quarterly)|Caribou Biosciences Inc Total Employees (Annual)|Caribou Biosciences Inc EPS Diluted (Quarterly) (USD)|Caribou Biosciences Inc SG&A Expense (Quarterly) (USD)|Caribou Biosciences Inc Shares Outstanding|Caribou Biosciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Caribou Biosciences Inc Ordinary Shares Number (Quarterly)|Caribou Biosciences Inc Payout Ratio|Caribou Biosciences Inc Quick Ratio (Quarterly)|Caribou Biosciences Inc Normalized Diluted EPS (Quarterly) (USD)|Caribou Biosciences Inc Stock Buybacks (Quarterly) (USD)|Caribou Biosciences Inc Effective Tax Rate (TTM)|Caribou Biosciences Inc Return on Equity|Caribou Biosciences Inc Net Income (TTM) (USD)|Caribou Biosciences Inc Revenue (TTM) (USD)|Caribou Biosciences Inc Dividend Per Share (Quarterly) (USD)|Caribou Biosciences Inc Revenue (Quarterly) (USD)|Caribou Biosciences Inc Gross Profit (Quarterly) (USD)|Caribou Biosciences Inc Pre-Tax Income (Quarterly) (USD)|Caribou Biosciences Inc Net Income (Quarterly) (USD)|Caribou Biosciences Inc Net Interest Income (Quarterly) (USD)|Caribou Biosciences Inc Price (USD)|Caribou Biosciences Inc Total Return Price (USD)|Caribou Biosciences Inc Enterprise Value (USD)|Caribou Biosciences Inc 30-Day Average Daily Volume|Caribou Biosciences Inc 1 Year Price Returns (Daily)|Caribou Biosciences Inc Short Interest|Caribou Biosciences Inc PE Ratio (Forward)|Caribou Biosciences Inc PE Ratio (Forward 1y)|Caribou Biosciences Inc PS Ratio (Forward)|Caribou Biosciences Inc PS Ratio (Forward 1y)|Caribou Biosciences Inc Quarterly EPS Estimates (USD)|Caribou Biosciences Inc Quarterly Revenue Estimates (USD)|Caribou Biosciences Inc Quarterly EPS Surprise|Caribou Biosciences Inc Quarterly Revenue Surprise|Caribou Biosciences Inc Quarterly Actual EPS (USD)|Caribou Biosciences Inc Quarterly Actual Revenue (USD)|Caribou Biosciences Inc Revenue Estimates for Current Fiscal Year (USD)|Caribou Biosciences Inc Revenue Estimates for Next Fiscal Year (USD)|Caribou Biosciences Inc Price Target (USD)|Caribou Biosciences Inc Consensus Recommendation|Caribou Biosciences Inc Price Target Num Estimates|Caribou Biosciences Inc EPS Estimates for Current Fiscal Year (USD)|Caribou Biosciences Inc EPS Estimates for Next Fiscal Year (USD)|Caribou Biosciences Inc Research and Development Expense (Quarterly) (USD)|Caribou Biosciences Inc Reconciled Depreciation (Quarterly) (USD)|Caribou Biosciences Inc Non-Operating Interest Expense (Quarterly) (USD)|Caribou Biosciences Inc Land and Improvements (Quarterly) (USD)|Caribou Biosciences Inc Buildings and Improvements (Quarterly) (USD)|Caribou Biosciences Inc Other Properties (Quarterly) (USD)|Caribou Biosciences Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0333|CRBU|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0333|CRBU||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0333|CRBU||5|5|91|91|0|91|0|91|91|91|0|91|91|0|1.43835616438|0|1.43835616438|0|1.43835616438|0|1.4387755102|0|91|1.43835616438|0|15.4166666667|91|91|91|92|0|0|0|0|30.6666666667|91.3333333333|0|91.3333333333|91.3333333333|15.5714285714|0|91|91|91|91.3333333333|91.25|91|0|91|91|0|91.3333333333|0|91.3333333333|91.3333333333|91.3333333333|1.43835616438|1.43835616438|1.43835616438|1.44444444444|0|15.4166666667|0|0|1.44117647059|1.44117647059|92|92|92|92|92|92|20.1111111111|30.1666666667|18.4|16.7272727273|18.4|45.25|36.2|91.3333333333|91.3333333333|91.3333333333|0|0|91|91
new_0222_0333|CRBU||6|6|3|3|0|3|0|3|3|3|0|3|3|0|146|0|146|0|146|0|98|0|3|146|0|12|3|3|3|1|0|0|0|0|6|6|0|6|6|7|0|3|3|3|6|4|3|0|3|3|0|6|0|6|6|6|146|146|146|117|0|12|0|0|34|34|2|2|1|1|1|1|9|6|10|11|10|4|5|6|6|6|0|0|3|3
new_0222_0333|CRBU||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0333|CRBU|202003|202003|202003||||||||||||||||||||||||||||||||||27.6574||-0.3543|3.489||||||-0.3307|||||||1.701||-11.002|-9.8|0.139||||||||||||||||||||||||8.641|0.226|0.003||||
new_0222_0333|CRBU|202006|202006|202006||||||||||||||||||||||||||||||||||27.6574||-0.0677|3.153||||||-0.0677|||||||8.478||-1.922|-1.872|0.006||||||||||||||||||||||||7.58|0.228|0.005||||
new_0222_0333|CRBU|202009|202009|202009||||||||||||||||||||||||||||||||||27.6574||-0.2868|3.247||||||-0.2868|0||||||1.198||-8.146|-7.933|-0.002||||||||||||||||||||||||6.18|0.226|0.006||||
new_0222_0333|CRBU|202012|202012|202012|24.306|15.953||3.502||18.16|12.389|5.771||-23.437|-30.871||||||||||0.0882||||5.16|2.606|41.324|||||||27.6574||-0.5316|4.173|||54.7092|0|1.7042|-0.5316||5.035||-34.308|12.361||0.984||-15.057|-14.703|0.073||||||||||||||||||||||||12.024|0.22|0.006|||5.038|0.38
new_0222_0333|CRBU|202103|202103|202103|155.925|145.924||3.38||53.504|22.21|31.294||-35.689|-44.03||||||||||0.0138||||5.825|3.122|150.151|||||||27.6574||-0.48|4.596|||54.7092|0|6.8325|-0.48||1.6116||-37.667|12.246||1.586||-13.159|-13.159|-0.001||||||||||||||||||||||||10.165|0.221|0.005|||5.135|0.38
new_0222_0333|CRBU|202106|202106|202106|142.967|129.524||4.408||55.938|26.007|29.931||-47.691|-58.341||||||||||0||||8.407|4.034|150.151|-63.1681||||||54.7092||-0.2616|5.113|||54.7092|0|5.3036|-0.2905||1.1189||-50.106|5.244||1.476||-14.311|-14.311|0.044|||||||||||0.4728|30|-427.6296|-95.08|-1.549|1.476||||||||12.327|0.23|0.002|||5.949|0.391
new_0222_0333|CRBU|202107|202106|202106|||||||||||||179.1219||-66.8552||106.3329|||||0||0.7569|||||||||17.0766||76|||56.7092|||||||||||||||||16.2|16.2|939.315|||429224||||||||||||||||||||||||
new_0222_0333|CRBU|202108|202106|202106|||||||||||||314.9946||-117.5681||178.5343|||||0||1.6694|||||||||15.907|||||59.9708|||||||||||||||||27.2|27.2|1651.8318|||1001159|||||||||||27.5|8.3333|29.6667|1.6667|3|-0.83|-1.5159|||||||
new_0222_0333|CRBU|202109|202109|202109|449.047|435.31||4.477||57.559|26.158|31.401||404.401|-79.315||124.3174|-15.7949|-44.843|2.1591|115.9684||3.5428||0|0|-22.4065|2.753|7.785|3.482|0.006|-39.3215||||-84.8796|65.9808|45.8896||-0.46|6.76|60.0213||60.0213|0|16.9392|-0.4076|-321.02|0.5575|-84.8796|-63.147|8.023||3.977||-20.974|-20.974|0.022|23.87|23.87|997.3984|863955.4667||1652365|||||-0.24|3|-68.75|32.5667|-0.405|3.977|11.531|12.5|30.6667|1.6667|3|-1.54|-1.47|15.833|0.26|0|||6.245|0.401
new_0222_0333|CRBU|202110|202109|202109|||||||||||||111.1506||-40.0936||107.4178||3.2816|||0||1.9258|||||||||65.6548||||||||||||||||||||||22.11|22.11|891.7609|500995.7333||1155884||||||||||||||||||||||||
new_0222_0333|CRBU|202111|202109|202109|||||||||||||85.2127||-30.7374||90.3164||2.767|||0||3.2015|||||||||66.0107|||||60.1921|||||||||||||||||18.59|18.59|683.6611|342785.7667||1927039|||||||||||11.5016|13.6|31.2|1.2|5|-2.27|-2.07|||||||
new_0222_0333|CRBU|202112|202112|202112|||||||||||||58.9541||-21.2656||73.3123||2.246|||0||4.3884|||||||||66.9579||||||||||||||||||||||15.09|15.09|472.9888|415289.8||2641461|||66.7867|49.7698|-0.34|4.8242|||||11.4372|||||||||||||
new_0222_0333|CRBU|202201|202112|202112|||||||||||||26.2435||-9.4664||52.1299||1.5971|||0||4.993|||||||||67.4546||||||||||||||||||||||10.73|10.73|210.5512|540835.9667||3005404|||47.4898|35.3897||||||||||||||||||||
new_0222_0333|CRBU|202202|202112|202112|||||||||||||20.7667||-7.4908||48.5833||1.4884|||0|||||||||||||||||||||||||||||||||10|10|166.611|583858.5667|||||42.3138|35.6023|||||||14.2252|16.9068|29.1667|1.1667|6|-1.765|-1.95|||||||